Spring til hovednavigation Spring til søgning Spring til hovedindhold

AMPKα1-LDH pathway regulates muscle stem cell self-renewal by controlling metabolic homeostasis

  • Marine Theret
  • , Linda Gsaier
  • , Bethany Schaffer
  • , Gaëtan Juban
  • , Sabrina Ben Larbi
  • , Michèle Weiss-Gayet
  • , Laurent Bultot
  • , Caterina Collodet
  • , Marc Foretz
  • , Dominique Desplanches
  • , Pascual Sanz
  • , Zizhao Zang
  • , Lin Yang
  • , Guillaume Vial
  • , Benoit Viollet
  • , Kei Sakamoto
  • , Anne Brunet
  • , Bénédicte Chazaud
  • , Rémi Mounier*
  • *Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

Control of stem cell fate to either enter terminal differentiation versus returning to quiescence (self-renewal) is crucial for tissue repair. Here, we showed that AMP-activated protein kinase (AMPK), the master metabolic regulator of the cell, controls muscle stem cell (MuSC) self-renewal. AMPKα1−/− MuSCs displayed a high self-renewal rate, which impairs muscle regeneration. AMPKα1−/− MuSCs showed a Warburg-like switch of their metabolism to higher glycolysis. We identified lactate dehydrogenase (LDH) as a new functional target of AMPKα1. LDH, which is a non-limiting enzyme of glycolysis in differentiated cells, was tightly regulated in stem cells. In functional experiments, LDH overexpression phenocopied AMPKα1−/− phenotype, that is shifted MuSC metabolism toward glycolysis triggering their return to quiescence, while inhibition of LDH activity rescued AMPKα1−/− MuSC self-renewal. Finally, providing specific nutrients (galactose/glucose) to MuSCs directly controlled their fate through the AMPKα1/LDH pathway, emphasizing the importance of metabolism in stem cell fate.

OriginalsprogEngelsk
TidsskriftEMBO Journal
Vol/bind36
Udgave nummer13
Sider (fra-til)1946-1962
Antal sider17
ISSN0261-4189
DOI
StatusUdgivet - 3 jul. 2017
Udgivet eksterntJa

Finansiering

This work was funded by grants from a European Commission integrated project (LSHM-CT-2004-005272), the Framework Programme FP7 Endostem (under grant agreement 241440), the Association Fran?aise contre les Myopathies, Ligue Nationale Contre le Cancer, and the Soci?t? Fran?aise de Myologie. We thank D.G. Hardie (Dundee University, Scotland, UK) for providing antibodies against AMPK?1, R.A. Depinho (University of Texas, Austin, TX) for providing the LKB1fl/fl mice, Pierre Rocheteau for providing antibody against TOM22 (Institut Pasteur, Paris, France), T. Andrieu and S. Dussurgey from the AniRA-Cytometry platform (UMS 3444?SFR Gerland Biosciences, Lyon, France) for their expertise in cell sorting, and Frederic Bouillaud for his expertise and help in bioenergetics and metabolism (Institut Cochin, Paris, France).

Citationsformater